Merck Mercuriadis In The News

Hipgnosis Songs Fund’s Chairman is determined to abolish Merck Mercuriadis’ ‘call option’. He was less bothered when Round Hill Music Royalty Fund’s investment manager had a near-identical clause.

A tale of two call options...

Merck Mercuriadis seems willing – currently – to trade in his ‘call option’ at Hipgnosis Songs Fund. So why is the company’s board offering to ‘bribe’ potential bidders with a £20 million bung in an attempt to offset it?

Yesterday, this saga took a turn for the bizarre

Hipgnosis Songs Fund’s board is concerned over Citrin Cooperman’s latest valuation of the company. What’s it going to do about it?

Hipgnosis Songs Fund delayed its results today. Why did it do it - and what does it really mean?

Hipgnosis Songs Fund sells 20,000 songs for $23.1m

Hipgnosis has not confirmed the name of the buyer

Hipgnosis Song Management appoints Daniel Pounder as CFO, Jonathan Baker as General Counsel

HSM currently services two clients: the Blackstone-backed private fund, Hipgnosis Songs Capital, and the UK-listed Hipgnosis Songs Fund

Hipgnosis Songs Fund names Rob Naylor as new Chairman, Francis Keeling as non-executive director

Former Round Hill board members jump over to Hipgnosis Songs Fund amid continuation turbulence

From Spotify changing its royalty model to Universal’s $3bn in Q3… it’s MBW’s Weekly Round-Up

The five biggest stories to hit our headlines over the past seven days

Hipgnosis Songs Fund has been left concussed by ‘discontinuation’. But with a seemingly rock solid ‘call option’, Merck Mercuriadis still holds all the cards.

On: Hipgnosis Songs Fund, the all important 'call option', Blackstone, and the most likely outcome of this week's mess